|
14 Mar 2024 – Research update from the MCM team (March 2024) |
|
|
|
We continue to characterise lung cancer biomarkers identified in the MCM1 project. This update focuses on HSD17B11, a gene associated with lung cancer survival. HSD17B11 is a protein coding gene, relatively ubiquitously expressed across organs and tissues. It is a short-chain alcohol dehydrogenase that metabolises secondary alcohols and ketones. |
|
|
Tags:
Project Update
|
|
|
|
|
16 Jan 2024 – Research update from the MCM team (January 2024) |
|
|
|
We continue our work on characterizing lung cancer biomarkers identified in the MCM1 project. This update focuses on PCSK5, a gene associated with lung cancer survival and which shows differential expression across various cancer types. |
|
|
Tags:
Project Update
|
|
|
|
27 Nov 2023 – Research update from the MCM team (November 2023) |
|
|
|
We continue our work on characterizing lung cancer biomarkers identified in the MCM1 project. This update focuses on IL13RA1, a gene associated with lung cancer survival and differentially expressed across multiple cancer types compared to normal tissues. |
|
|
Tags:
Project Update
|
|
|
|
|
15 Sep 2023 – MCM team update: ADH6 |
|
|
|
We continue our work on characterizing lung cancer biomarkers identified in the MCM1 project. This update focuses on ADH6, a gene associated with smoking status and lung cancer prognosis. |
|
|
Tags:
Project Update
|
|
|
|
12 Jul 2023 – MCM team has been researching GSDMB |
|
|
|
We continue our work on characterizing lung cancer biomarkers identified in the MCM1 project. This update focuses on GSDMB, a gene associated with lung cancer survival and differentially expressed across multiple cancer types compared to normal tissues. |
|
|
Tags:
Project Update
|
|
|
|
28 Apr 2023 – Research update from the MCM team (April 2023) |
|
|
|
The MCM team’s research into lung cancer biomarkers has identified 26 genes that are present with top scores across all the signature sizes considered. This update focuses on a potential biomarker gene called FARP1, which is linked to lung cancer metastasis. |
|
|
Tags:
Project Update
|
|
|
|
20 Mar 2023 – Research update from the MCM team (March 2023) |
|
|
|
The MCM team’s research into lung cancer biomarkers has identified 26 genes that are present with top scores across all the signature sizes considered. This update focuses on VAMP1, a gene linked to patient survival and differentially expressed in normal lung compared to lung cancer. |
|
|
Tags:
Project Update
|
|
|
|
01 Apr 2022 – Mapping Cancer Markers Q&A |
|
|
|
Mapping cancer markers researchers answer questions asked on the forum |
|
|
Tags:
Project Update
|
|
|